Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine: COMMENT from Gruel et al.: RESPONSE from Kahn et al

被引:2
|
作者
Kahn, Fredrik [1 ]
Shannon, Oongh [1 ]
Bjorck, Lars [1 ]
机构
[1] Lund Univ, Div Infect Med, Clin Sci, Lund, Sweden
关键词
drug-related side effects and adverse reactions; IdeS; platelet factor 4; thrombocytopenia; vaccine; IDES;
D O I
10.1111/jth.15467
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2633 / 2633
页数:1
相关论文
共 50 条
  • [21] Response to: 'Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort' by Costa et al
    Gupta, Latika
    Misra, Durga Prasanna
    Agarwal, Vishwesh
    Balan, Suma
    Agarwal, Vikas
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (04)
  • [22] Response to "Moghnieh et al. COVID-19: Second Wave or Multiple Peaks, Natural Herd Immunity or Vaccine - We Should be Prepared"
    Khalid, Dua
    Khalid, Haya
    Mahmood, Syed Uzair
    Choudry, Erum
    DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS, 2022, 16 (03) : 852 - 852
  • [23] Response to Comment on "ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank" by Kuo et al.
    Kuo, Chia-Ling
    Melzer, David
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2020, 75 (11): : 2235 - 2236
  • [24] Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID-19: Response from Original Authors Susen, et al.
    Susen, Sophie
    Rauch, Antoine
    Lenting, Peter J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (12) : 3385 - 3386
  • [25] Response to Kim et al. re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19"
    Sengupta, Vikram
    Sengupta, Sascha
    Lazo, Angel, Jr.
    Hicok, Kevin C.
    Moseley, Timothy
    STEM CELLS AND DEVELOPMENT, 2020, 29 (14) : 879 - 881
  • [26] Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al.
    Martora, Fabrizio
    Villani, Alessia
    Marasca, Claudio
    Fabbrocini, Gabriella
    Ruggiero, Angelo
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (01) : E103 - E105
  • [27] Authors' reply to: Rivera-Lillo et al. comment on: Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 rehabilitation unit and proposal of a treatment protocol
    Curci, Claudio
    Pisano, Fabrizio
    Negrini, Francesco
    de Sire, Alessandro
    EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2021, 57 (01) : 172 - 173
  • [28] "Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?" Comment from Wada et al
    Wada, Hideo
    Matsumoto, Takeshi
    Shiraki, Katsuya
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (12) : 3647 - 3649
  • [29] Response to: 'The role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients' by Favalli et al
    Romao, Vasco C.
    Cruz-Machado, Ana Rita
    Fonseca, Joao Eurico
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (05)
  • [30] REPLY TO NEPOMUCENO ET AL.: A renewed call for detailed social and demographic COVID-19 data from all countries
    Dowd, Jennifer Beam
    Andriano, Liliana
    Brazel, David M.
    Rotondi, Valentina
    Block, Per
    Ding, Xuejie
    Mills, Melinda C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (25) : 13884 - 13885